Literature DB >> 20308058

Hsc70 rapidly engages tau after microtubule destabilization.

Umesh K Jinwal1, John C O'Leary, Sergiy I Borysov, Jeffrey R Jones, Qingyou Li, John Koren, Jose F Abisambra, Grant D Vestal, Lisa Y Lawson, Amelia G Johnson, Laura J Blair, Ying Jin, Yoshinari Miyata, Jason E Gestwicki, Chad A Dickey.   

Abstract

The microtubule-associated protein Tau plays a crucial role in regulating the dynamic stability of microtubules during neuronal development and synaptic transmission. In a group of neurodegenerative diseases, such as Alzheimer disease and other tauopathies, conformational changes in Tau are associated with the initial stages of disease pathology. Folding of Tau into the MC1 conformation, where the amino acids at residues 7-9 interact with residues 312-342, is one of the earliest pathological alterations of Tau in Alzheimer disease. The mechanism of this conformational change in Tau and the subsequent effect on function and association to microtubules is largely unknown. Recent work by our group and others suggests that members of the Hsp70 family play a significant role in Tau regulation. Our new findings suggest that heat shock cognate (Hsc) 70 facilitates Tau-mediated microtubule polymerization. The association of Hsc70 with Tau was rapidly enhanced following treatment with microtubule-destabilizing agents. The fate of Tau released from the microtubule was found to be dependent on ATPase activity of Hsc70. Microtubule destabilization also rapidly increased the MC1 folded conformation of Tau. An in vitro assay suggests that Hsc70 facilitates formation of MC1 Tau. However, in a hyperphosphorylating environment, the formation of MC1 was abrogated, but Hsc70 binding to Tau was enhanced. Thus, under normal circumstances, MC1 formation may be a protective conformation facilitated by Hsc70. However, in a diseased environment, Hsc70 may preserve Tau in a more unstructured state, perhaps facilitating its pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308058      PMCID: PMC2878041          DOI: 10.1074/jbc.M110.113753

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Review: mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones.

Authors:  A P Ben-Zvi; P Goloubinoff
Journal:  J Struct Biol       Date:  2001-08       Impact factor: 2.867

2.  Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.

Authors:  G A Jicha; R Bowser; I G Kazam; P Davies
Journal:  J Neurosci Res       Date:  1997-04-15       Impact factor: 4.164

3.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

4.  Structure solution of misfolded conformations adopted by intrinsically disordered Alzheimer's tau protein.

Authors:  Jozef Sevcik; Rostislav Skrabana; Eva Kontsekova; Michal Novak
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

5.  Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

Authors:  C L Weaver; M Espinoza; Y Kress; P Davies
Journal:  Neurobiol Aging       Date:  2000 Sep-Oct       Impact factor: 4.673

6.  Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone.

Authors:  Mitul Sarkar; Jeff Kuret; Gloria Lee
Journal:  J Neurosci Res       Date:  2008-09       Impact factor: 4.164

Review 7.  New tricks for an old dog: the evolving world of Hsp70.

Authors:  Kevin A Morano
Journal:  Ann N Y Acad Sci       Date:  2007-05-18       Impact factor: 5.691

8.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Transmission and spreading of tauopathy in transgenic mouse brain.

Authors:  Florence Clavaguera; Tristan Bolmont; R Anthony Crowther; Dorothee Abramowski; Stephan Frank; Alphonse Probst; Graham Fraser; Anna K Stalder; Martin Beibel; Matthias Staufenbiel; Mathias Jucker; Michel Goedert; Markus Tolnay
Journal:  Nat Cell Biol       Date:  2009-06-07       Impact factor: 28.824

10.  Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.

Authors:  Anatoli B Meriin; Xiaoqian Zhang; Xiangwei He; Gary P Newnam; Yury O Chernoff; Michael Y Sherman
Journal:  J Cell Biol       Date:  2002-06-10       Impact factor: 10.539

View more
  48 in total

1.  Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease.

Authors:  Karl Herrup; Maria C Carrillo; Dale Schenk; Angela Cacace; Susan Desanti; Robert Fremeau; Ratan Bhat; Marcie Glicksman; Patrick May; Russell Swerdlow; Linda J Van Eldik; Lisa J Bain; Samantha Budd
Journal:  Alzheimers Dement       Date:  2013-07       Impact factor: 21.566

2.  Tau protein aggregates inhibit the protein-folding and vesicular trafficking arms of the cellular proteostasis network.

Authors:  Anan Yu; Susan G Fox; Annalisa Cavallini; Caroline Kerridge; Michael J O'Neill; Joanna Wolak; Suchira Bose; Richard I Morimoto
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

Review 3.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

Review 4.  Molecular chaperones and regulation of tau quality control: strategies for drug discovery in tauopathies.

Authors:  Yoshinari Miyata; John Koren; Janine Kiray; Chad A Dickey; Jason E Gestwicki
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

5.  Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement.

Authors:  Sarah N Fontaine; Jennifer N Rauch; Bryce A Nordhues; Victoria A Assimon; Andrew R Stothert; Umesh K Jinwal; Jonathan J Sabbagh; Lyra Chang; Stanley M Stevens; Erik R P Zuiderweg; Jason E Gestwicki; Chad A Dickey
Journal:  J Biol Chem       Date:  2015-04-11       Impact factor: 5.157

Review 6.  Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-09-28       Impact factor: 3.444

7.  DnaJA1 antagonizes constitutive Hsp70-mediated stabilization of tau.

Authors:  Jose F Abisambra; Umesh K Jinwal; Amirthaa Suntharalingam; Karthik Arulselvam; Sarah Brady; Matthew Cockman; Ying Jin; Bo Zhang; Chad A Dickey
Journal:  J Mol Biol       Date:  2012-02-15       Impact factor: 5.469

8.  Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport.

Authors:  Kristina R Patterson; Sarah M Ward; Benjamin Combs; Kellen Voss; Nicholas M Kanaan; Gerardo Morfini; Scott T Brady; T Chris Gamblin; Lester I Binder
Journal:  Biochemistry       Date:  2011-11-08       Impact factor: 3.162

9.  Changes in proteome solubility indicate widespread proteostatic disruption in mouse models of neurodegenerative disease.

Authors:  Michael C Pace; Guilian Xu; Susan Fromholt; John Howard; Keith Crosby; Benoit I Giasson; Jada Lewis; David R Borchelt
Journal:  Acta Neuropathol       Date:  2018-08-23       Impact factor: 17.088

10.  Synthesis and initial evaluation of YM-08, a blood-brain barrier permeable derivative of the heat shock protein 70 (Hsp70) inhibitor MKT-077, which reduces tau levels.

Authors:  Yoshinari Miyata; Xiaokai Li; Hsiu-Fang Lee; Umesh K Jinwal; Sharan R Srinivasan; Sandlin P Seguin; Zapporah T Young; Jeffrey L Brodsky; Chad A Dickey; Duxin Sun; Jason E Gestwicki
Journal:  ACS Chem Neurosci       Date:  2013-03-20       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.